Allergen-specific immunotherapy (desensitisation) is the only disease-modifying treatment for canine atopy. Long-term outcomes show 50-70% of dogs achieve significant improvement with sustained commitment.
Allergen-specific immunotherapy offers the prospect of disease modification rather than lifelong symptom management, reducing suffering rather than merely masking it. Dogs that respond to immunotherapy achieve meaningful reduction in chronic itch, skin inflammation, and secondary infection that significantly improves quality of life. The required long-term commitment is worthwhile for responding animals.